It found that tirzepatide patients who also implemented positive lifestyle changes lost on average 21% of their body weight over the course of 18 months
Support: This is an independent discussion produced by Radcliffe Cardiology
fortuitum 24,27,29,35,43,4648,52,53
When used thoughtfully, this combination offers many of the same therapeutic benefits as Qsymia while providing greater flexibility in managing each medications contribution to weight loss
The majority of relevant research has used liraglutide (Saxenda) and semaglutide (Wegovy) as the study medications, with tirzepatide (Mounjaro) generating significant interest given its dual GLP-1 and GIP receptor action
These drugs help regulate blood sugar, reduce appetite, and promote weight loss by mimicking a natural hormone in the body